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Abstract
Background: Infected schwannoma has been reported, this being one of the four cases published in the literature.
Infected schwannoma has proven to be a tough diagnostic challenge to the treating tumor surgeon, mimicking
infectious entities and most essentially, a malignant tumor.
Case presentation: The authors report the case of a 64-year-old male with a soft tissue mass in his right gluteal
area that presented initially with right leg pain, then later with signs of inflammation on the tumor area. Magnetic
resonance imaging (MRI), computed tomography (CT), and thallium-201 scintigraphy studies confirm the presence
of soft tissue mass which had continuity with sciatic nerve, with subsequent serial MRI findings suggesting tumor
enlargement with cystic degeneration. Increased level of C-reactive protein (CRP) was observed before surgery.
During an open biopsy upon tissue sampling, exudates with necrotic tissue were seen. Increased level of CRP and
necrotic change suggested the possibility of malignant tumor. Histopathological diagnosis was schwannoma, and
group B Streptococcus was detected by culture. After the confirmation of infected schwannoma, enucleation of the
tumor was performed.
Conclusions: The report concludes that establishment of a benign pathology is essential when presented with
similar clinical findings prior to definitive enucleation of an infected schwannoma.
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Background
Schwannoma is an unusual benign tumor arising from
the nerve sheath comprising of Schwann cells [1]. Com-
mon locations include the head and neck, the flexor sur-
faces of the upper and lower extremities, the posterior
mediastinum in the thorax, and the trunk [2]. The be-
nign tumor is commonly 2 to 4 cm in size but can
become large in deep tissues like the posterior mediasti-
num or retroperitoneum [2]. Larger tumors can present
with pain and neurological symptoms clinically, and cys-
tic formation can be seen due to degenerative changes
histopathologically [3].
Schwannomas mostly arise adjacent to a peripheral,
or less commonly an intracranial nerve [1]. These tu-
mors occur principally in adults and equally in males
and females [1] but are less common in children [4].
The lesions are round and quite smooth and regular
in appearance and are tightly attached to the neural
elements [1].
These benign tumors are occasionally glandular in
structure [5]. But histologically, schwannoma tissue has
some remarkable features that are not only quite dis-
tinctive but denote major diagnostic elements. These
features include Antoni A patterns in which the cells are
elongated as are their nuclei; [6] Antoni B patterns in
which the cells are irregular and the tissue between
them are markedly hyalinized; [3, 6, 7] and Verocay bod-
ies which show large collections of fibrous elements be-
tween the Antoni A cells [8, 9]. In addition, the tumor
tissue may contain Wagner–Meissner bodies with
xanthomatous changes [10]. All the cells stain weightily
with S100 [6, 9, 10].
Infected schwannoma does happen but is extremely
rare. After a thorough review and to the best of the au-
thors’ knowledge, this is one of the only four cases of in-
fected schwannoma reported in the literature. The other
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three were cases of infected gastric [11], retroperitoneal
[12], and glossal [13] schwannomas. But more interest-
ing than the rarity of infected schwannoma is the diag-
nostic challenge that a similar vagueness of its clinical
presentation poses to the treating tumor surgeon.
Schwannoma has been reported in the literature mim-
icking infectious disease entities such as psoas abscess
[14, 15], nerve abscess of leprosy [16–18], Bartholin’s
gland abscess [19], and acute appendicitis [20]. It has
also been reported as presenting concomitantly with,
and hidden by, an infectious pathology [21, 22]. A simi-
lar clinical presentation can also be thought of a malig-
nant tumor undergoing rapid growth and subsequent
necrotic change and cystic degeneration within the mass
[23–25]. Lastly, cases of malignant transformation of a
schwannoma have been documented in the literature
[26–28], some being radiation-induced [29, 30] and
sometimes even to an angiosarcoma [31–35].
The authors report the case of a 64-year-old male who
received steroid pulse therapy at another hospital and
presented with an infected schwannoma in his right
gluteal area. This report underscores the importance of
establishing a benign tumor diagnosis by final histo-
pathology prior to definitive enucleation of the mass
when presented with findings suggestive of an in-
fected schwannoma.
Case presentation
A 64-year-old male had suffered from right leg pain ac-
companying an enlarging mass in his right gluteal area.
The patient received steroid pulse therapy because of
sudden deafness at another hospital at 5 months prior to
consult. Right leg pain appeared 1 month later. There
was no neurological deficit.
A firm, soft tissue mass with poor mobility was pal-
pated deep to the area of the right gluteal crease. Before
surgery, Tinel’s sign was positive. Computed tomography
(CT) showed no phleboliths or foci of calcification
within the tumor, and thallium-201 scintigraphy showed
accumulation on the area of the mass (see Fig. 1). Mag-
netic resonance imaging (MRI) showed enlargement and
homogenous contents with high T2-weighted signal in-
tensities, suggesting cystic degeneration (see Fig. 2a, b).
Elevated C-reactive protein (CRP) and increased white
blood cells (WBC) were observed before surgery. Differ-
ential diagnoses comprised of schwannoma and sarco-
mas including malignant peripheral nerve sheath tumor
with necrotic change.
Before excision of the tumor, an open biopsy was per-
formed. During the open biopsy, exudate with necrotic
tissue was seen (see Fig. 3). A part of the tumor tissue
and the exudate was obtained. Pathologic findings show
spindle-shaped, S100-positive cells arranged in fascicles
with no nuclear atypia, with scattered lymphocytes and
degenerative necrotic changes. Culture of the exudate
yielded group B Streptococcus, and postoperative antibi-
otics were shifted to intravenous cefazolin, at a dose
500 mg every 8 hours. Taken together, the mass was di-
agnosed as infected schwannoma.
After the confirmation of the existence of bacteria and
pathological diagnosis released 5 days following the open
biopsy, enucleation was imperative because CRP and
WBC counts were persistently elevated (see Table 1).
Enucleation of the mass with debridement and irrigation
was performed on the day of release of the final histo-
pathological report. The mass had a thickened capsule
and was seen attached to the sciatic nerve (see Fig. 4).
Nerve stimulator was used during surgery to prevent
postoperative motor deficits. Following tumor removal,
debridement of surrounding devitalized tissues and copi-
ous irrigation with saline solution was done.
The mass was round, firm, and brownish-yellow in
color, measuring 11 cm × 6.5 cm × 5 cm (see Fig. 5).
Gross (see Fig. 6a) and histopathologic findings with
hematoxylin and eosin staining (see Fig. 6b, c) revealed
cystic necrotic tumor degeneration with abundance of
macrophages and lymphocytes accompanying Antoni A
and B cells, consistent with a diagnosis of schwannoma
with degenerative changes. Culture yielded group B
Streptococcus. The patient was continually administered
intravenous cefazolin for 1 week, and oral cefdinir for
1 month. Successive CRP determinations decreased (see
Table 1), and the pain had been improved after the
surgery.
Conclusions
Schwannomas larger than 5 cm in diameter have a ten-
dency to undergo cystic degenerative change [36, 37].
Moreover, the cyst formation itself makes the tumor
Fig. 1 Thallium-201 scintigraphy showing uptake at the area of
tumor (see arrow)
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even larger [38]. The proposed mechanism for degener-
ation is the vascular insufficiency resulting from the in-
crease in size—the poor vascular supply results to
necrosis, hemorrhage, blood resorption, and hyaline de-
generation within the tumor that subsequently leads to
cyst formation [39, 40]. This cystic degenerative change
is also commonly seen in ancient schwannomas, first de-
scribed by Ackerman and Taylor in 1951, that is com-
prised entirely of Antoni type B tissue [41]. It is
considered that degenerative change producing poor
vascularization within the tumor provides the nidus for
hematogenous infection of a schwannoma.
Malignant tumors, however, due to their inherent
rapid growth, can undergo the same internal necrosis
[23–25] and, therefore, present comparably as large
schwannomas undergoing cystic degenerative change. A
differential diagnosis also worth mentioning is the in-
flammatory subtype of undifferentiated pleomorphic sar-
coma, which mimics an abscess clinically and presents
with constitutional symptoms including fever and mal-
aise in addition to an elevated CRP and erythrocyte sedi-
mentation rate (ESR) [23]. Malignant transformation of
a schwannoma has been documented in many published
reports [26–28, 31–35]. Seeing exudates with necrotic
tissue during the open biopsy made it difficult to deter-
mine the diagnosis not only because of the rarity of an
infected schwannoma [11–13] but more so, of the possi-
bility of a malignant pathology. The authors thought it
prudent to wait for the final histopathological report
before deciding on a definite surgical plan to avoid
“undertreating” the case in the event that the diagnosis
turned out to be a malignancy.
Previous reports cited at the beginning of this paper
show how tricky a schwannoma diagnosis can be when
presented clinically with a backdrop similar to that of an
infectious pathology [14–22]. Although a homogenous
signal on T2-weighted MRI accompanying clinical signs
of infection in this case favors an abscess over a malig-
nant pathology, the reports imply that schwannoma
must be a competing differential diagnosis in such case.
An open biopsy, therefore, prior to a conclusive surgical
procedure, should be done. The authors have decided to
perform an open biopsy because in the present case,
there was cystic change of the mass, and the cystic
change made it difficult to obtain tumoral tissue by nee-
dle biopsy even if the biopsy is performed with the guid-
ance of ultrasonography or CT. The infected gastric
schwannoma case of Euanorasetr and Suwanthanma
[11] could have avoided a Billroth 2 procedure if only an
open biopsy was initially done that could have ruled out
their preoperative working diagnosis of gastric lymph-
oma. Two other gastric schwannoma cases [42, 43], also
misdiagnosed as malignancies preoperatively, ended up
with partial gastrectomies instead of just local tumor
Fig. 2 a, b T2-weighted (a) and T2-weighted fat-suppressed (b) MR images of mass showing the enlargement and homogenous appearance of
contents with high signal intensities, indicating cystic degeneration
Fig. 3 Pus coming out of tumor during open biopsy procedure
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extirpations [42]. Although these were cases of “over-
treatment” and not “undertreatment”, anatomical and
corresponding functional losses from the gastric surger-
ies are undesirable for a patient. Similarly, missing out
on a malignancy and subsequently “undertreating” a
tumor is never a desirable occurrence for the treating
tumor surgeon. Therefore, the authors of this case re-
port deemed the open biopsy prior to definitive surgery
very crucial.
Singh et al. [12], in their case of a large, infected retro-
peritoneal schwannoma, did not perform debridement
and irrigation following removal of the tumor, although
the postoperative recovery was purportedly uneventful.
In the present case, the authors performed debridement
and irrigation of devitalized peritumoral tissue following
tumor enucleation. With the use of nerve stimulator, re-
moval of nonviable tissue with the preservation of neural
structures was safely accomplished. The authors consid-
ered doing a debridement and irrigation important in
the present case to prevent recurrence of the infection.
The predominance of lymphocytes in both the open
biopsy and final histopathological reports in the present
case, in a supposedly acute bacterial infection, elucidates
the role of lymphocytes during ongoing, nonresolving
infection. Attention is traditionally placed on poly-
morphonuclear leukocytes (PMNs) in acute bacterial in-
fection, with the influx of PMNs unquestionably
observed at the initial phase and their accumulation
peaking by the 2nd day following onset of acute bacterial
infection [44]. In the present case, both the biopsy and
final histopathological analyses were performed at least a
week since CRP determinations were already elevated.
Lymphocytes disappear once PMNs begin to accumu-
late, in response to PGD2 working through its DP1
receptor. However, beyond the period of intense inflam-
mation when PMNs start to disappear, lymphocytes are
observed repopulating the site of inflammation [44].
Rajakariar et al. [44] have found lymphocytic repopula-
tion occurring not only during progression of the acute
infection but also during and beyond resolution, and
have concluded that lymphocytic repopulation during
acute inflammation does not primarily signal resolution,
but serves as the body’s preparation to mediate re-
sponses to a superinfection where lymphocytes are
observed to predominate. The timing of the histopatho-
logical studies shall explain the lymphocytic repopula-
tion and the absence of PMNs or bacterial bodies noted
in both the biopsy and final histopathological reports for
the present case, for which an imminent superinfection
must have been anticipated.
Group B Streptococcus (GBS) disease has emerged as a
major cause of invasive infections in adults for the past
three decades [45–49]. In a recent population-based sur-
veillance among California adults from 1995 to 2012
Table 1 CRP and WBC determinations (with neutrophil counts) before and after open biopsy
8 days before 2 days before 1 day after 3 days after 5 days after (DOE) 7 days after 10 days after
WBC (×103) 12.68 (H) 11.45 (H) 10.15 (H) 8.55 7.54 7 7.15
PMNs (%) 80.4 (H) 79 (H) ** 79.9 (H) 73.8 (H) 67 (H) 62
CRP (mg/dl) 18.7 (H) 10.8 (H) ** 11.5 (H) 8 (H) 6.9 (H) 5.5
PMNs polymorphonuclear leukocytes, CRP C-reactive protein, H high, WBC white blood cells, DOE date of enucleation
** PMNs and CRP had no results on this day
Fig. 4 Capsule (diamond arrow) and mass seen attached to the sciatic
nerve (round arrow)
Fig. 5 Schwannoma extirpated by enucleation
measuring 11 cm × 6.5 cm × 5 cm
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[50], the incidence has increased from 5.8 to 8.3 cases/
100,000 persons (p < 0.001), mostly among men aged
more than 40 years (p < 0.002). One study identified in-
creasing age as being associated with risk even after
adjusting for specific chronic illnesses which are more
frequent among older persons [47], and the clinical pres-
entation of invasive GBS disease among adults most
often takes the form of bacteremia with no identified
source [49, 51].
Taken altogether, the patient in the present case, with
a history of steroid pulse therapy and possibly of steroid-
induced immunosuppression, could have contracted the
infection from a silent GBS bacteremia. When presented
with an infected tumor in an adult allegedly immuno-
compromised, it is prudent that GBS disease must be
ruled out. Cefdinir, an oral cephalosporin relatively new
in the market, has been shown to have broad-spectrum
activity including against GBS [52]. The authors, there-
fore, tapered the intravenous antibiotic cefazolin to oral
cefdinir, considering the latter to be an ideal oral anti-
biotic for a patient allegedly immunocompromised. The
authors have also extended the regimen from the usual
2 weeks to 1 month, as prophylaxis for immune aug-
mentation given the background of possible steroid-
induced immunosuppression [53].
The authors conclude that establishment of a benign
tumor diagnosis by final histopathological analysis is es-
sential when presented with similar clinical findings
prior to definitive tumor enucleation of an infected
schwannoma.
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